Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“In clinical studies, 11% to 26% of people who took Darzalex and standard multiple myeloma treatment developed pneumonia.” “Chemo” could include very harmful chemicals. Darzalex
Continue readingEvidence-Based, Non-Toxic, Non-Conventional Cancer Therapies Will Eliminate Inflammation- If you’ve been diagnosed with pre-myeloma- SBP, MGUS or SMM- your blood disorder is not your worry. Your
Continue readingChronic systemic inflammation becomes increasingly associated with risk of death, loss of cognitive function and increasing dependency Could the progression of pre-MM (SBP, MGUS, SMM) be slowed or even
Continue readingMultiple myeloma is defined as smoldering (asymptomatic) or active (symptomatic). The NCCN criteria for smoldering multiple myeloma are as follows The presence of any of the CRAB criteria or any of
Continue reading“multiple myeloma patients aged 70 years or older undergoing autologous stem cell transplantation have better progression-free survival but no difference in OS compared to patients who do not undergo
Continue reading“…this study monitored patients for predictors of CVAEs and found a greater incidence, with 51% of (multiple myeloma treated w/ CFZ) patients experiencing CVAEs, including heart failure, hypertension,
Continue reading“Survival rates vary significantly by stage of the disease. Those with serious cancers (multiple myeloma) who are in stage 1, for example, may have better survival rates than those with stage 2 or
Continue readingDon’t Want to “Watch and Wait?” Reduce Your Risks of Multiple Myeloma, Lose a Few Pounds, Get Healthy and Feel Great- A diagnosis of monoclonal gammopathy of undetermined significance
Continue readingThe challenge for those newly diagnosed Multiple Myeloma patients that achieve remission is that the toxicity of those therapies can cause life-threatening side effects to the patient’s blood, bones,
Continue reading“Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow. Multiple myeloma is the most
Continue reading“The challenge for multiple myeloma survivors however, is that each proteasome inhibitor will stop working eventually. MDR aka multi-drug resistance is a fact for all multiple myeloma chemotherapy
Continue reading“The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies (MM).” Second only to “Why did I get
Continue reading